Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/5aad7a09-fe4a-41af-9f48-13cdece5f3e5/
KLRA
Kailera Therapeutics, Inc. Common StockSnapshot 2026-07-19 · 0.6w · Fresh
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
51.0%ile
FCF Yield
-0.051
SH Yield
-0.208
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
50.00000000
/100 — 1=cheapest
VC2 (Trending Value)
50.00000000
/100
VC3 (Buyback)
51.00000000
/100
Negative FCF yield (-5.1%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
49.0%ile
ROE
0.345
ROA
-0.238
D/E
-2.45
Current
9.67
F-Score
2/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Accruals
-0.046
lower=better
5yr Consist
No
ROE of 34% is exceptional. Conservative balance sheet with D/E of -2.45. F-Score of 2/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
50.0%ile
Vol 252d
66.7%
Vol 60d
64.7%
↓ Contracting
Max DD 12M
-28.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.54
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
33.5%
Sector Quality %ile
27.5%
Sector Avg OS
64.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
0.0% avg (2 factors)
Quality
A
75.4% avg (5 factors)
Risk
F
5.5% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.540 | —0 | — | |
| Value %ile | 0.510 | —0 | — | |
| Quality %ile | 0.490 | —0 | — | |
| Momentum %ile | 0.500 | —0 | — | |
| F-Score | 2.000 | —7 | — | |
| Confidence | 0.411 | —0 | — | |
| Volatility | 0.667 | —5 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
FCF Yield
-5.1%
Shareholder Yield
Div + net buyback / mktcap
-20.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
34.5%
Return on Assets
-23.8%
Debt / Equity
-2.45
Current Ratio
9.67
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.046
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
2
Buyback Yield
-20.8%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
50
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
50
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
51
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity